Genetic Testing for Cardiovascular
Conditions is an essential strategy
to better understand an individual’s risk
to develop potentially debilitating heart
and cardiovascular conditions.
Learning in advance if a patient is genetically predisposed to specific cardiovascular conditions and abnormalities is an important step to improve clinical management and inform a wide range of lifestyle recommendations and interventions.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) Panel (covers 21 genes)
Breakthrough Genomics’ Comprehensive
Cardiovascular Test features accurate
analysis of nearly 200 genes that can impact cardiovascular health.
This test is recommended for individuals with a family history of heart conditions of who are concerned about their long-term risk to develop heart diseases.
Benefits of genetic testing for cardiovascular conditions include:
informed recommendations for prevention and monitoring
improved clinical management decisions and treatment options
enhanced understanding of potential risk to family members
cost savings by eliminating the need for unnecessary screening
procedures and checkups